Investigations linking human megakaryocyte development and cell biology have been hindered by an inability to obtain large, relatively pure megakaryocyte cell preparations from in vitro stem cell cultures. We report here that such preparations can be generated from liquid cultures of normal human peripheral blood mononuclear cells stimulated by a serum source of megakaryocyte colony stimulating activity (Meg-CSA, the 0% to 60% ammonium sulfate protein fraction of aplastic canine serum). Adherentdepleted peripheral blood mononuclear cells are suspended at 5 x 106to 10' cells/mL in supplemented liquid culture medium, platelet-poor human plasma 20% (vol/vol) and 1 to 2 mg/mL serum Meg-CSA protein. After 12 to 14 days of incubation, megakaryocytes constitute 3.0 k 2.9% (mean f SD, n = 8) of the unseparated cultured cell population. Megakaryocytes can be enriched by counterflow centrifugal elutriation to a purity of 58 ? 14% (+SD) with a recovery of 13 k 7% and a viability of 67 k 19%. This algorithm results in the average isolation of approximately 3 x lo5 enriched megakaryocytes from a 100-mL starting NVESTIGATIONS of megakaryocyte cell biology have I been greatly hampered by the unavailability of large, relatively pure megakaryocyte cell preparations. This obstacle has been in part overcome by the development of techniques for enriching megakaryocytes from the bone marrow of experimental animals and humans.
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Using sequential density centrifugation and velocity sedimentation, Levine and Fedorko isolated 1.5 to 4.5 x lo5 megakaryocytes from the femurs of individual guinea pigs.lV2 These megakaryocyte preparations were 27% to 73% pure and approximately 90% viable based on trypan blue excluxsion.',2 The application of similar techniques to human bone marrow from surgically resected ribs resulted in average megakaryocyte yields of 1.3 x lo4 to 1.7 x lo5 cells, purities of 10% to 9496, and viabilities of 69% to 93%.3-5 Flow cytometric cell sorting and immunomagnetic bead adherence, when applied to human marrow aspirate specimens, result in megakaryocyte populations of high purities (98% to 100%) but only relatively small numbers (0.2 to 1 x lo5
Counterflow centrifugal elutriation (CCE), a method of cell separation dependent on cell size and density, has recently been used for megakaryocyte isolation from bone marrow. The application of CCE has been shown to improve megakaryocyte yield and recovery while maintaining a relatively high degree of purification.' From individual guinea pigs, megakaryocyte yields have been reported to average 1.8 x lo6 cells with purities of approximately 70%.* However, when applied to human bone marrow samples obtained by needle aspiration, CCE results in average megakaryocyte yields of only 2.5 x lo4 to 3.5 x lo5 cells and cell purities of only 7% to 22%. 8, 9 While megakaryocyte populations of lo5 to lo6 cells have proven suitable for some biochemical and functional analyses,lO." the limited availability of larger numbers of megakaryocytes has curtailed the investigation of many aspects of megakaryocyte molecular and cellular biology. This problem is exacerbated in studies of human megakaryocytes due to limitations in the quantity of bone marrow available and the variable health status of the donors." Furthermore, comparisons of the biochemical and functional characteristics of human megakaryocytes developing in different thrombopoietic regulatory environments have been impossible to perform.
Our laboratory and others have previously demonstrated that megakaryocytes will develop from progenitor cells (colony forming unit-megakaryocyte, CFU-Meg) in semisolid matrices when cultured with a source of megakaryocyte colony stimulating activity (Meg-CSA).I2-I4 Such techniques have been valuable in identifying growth stimulators of megakaryocytopoiesis and in preliminary analyses of the determinants of megakaryocyte polyploidizati~n.'~*~~ However, megakaryocytes grown in semisolid cultures are either permanently immobilized within the culture matrix or can be recovered only in limited quantities using the labor intensive process of visual colony identification and manual megakaryocyte extraction and pooling. Using this latter approach, Jenkins et a1 isolated up to lo5 stem cell derived megakaryocytes (70% to 90% pure) from methylcellulose cultures; cells that were 95% viable and were shown to synthesize platelet glycoproteins IIb and 1IIa.l' In this investigation, we have developed a liquid culture system for human CFU-Meg and combined this with megakaryocyte separation algorithms to generate large, highly enriched populations of human megakaryocytes. Megakaryocytes are grown from normal human peripheral blood mononuclear cells in liquid cultures containing a serum source of Meg-CSA. This approach has permitted the routine isolation of greater than lo5 stem cell derived megakaryocytes with purities of greater than 50% using an initial 100 mL sample of normal peripheral blood. The cultured megakaryocytes are morphologically normal, express platelet specific proteins, and exhibit the expected heterogeneity in DNA content. With the large number and purity of megakaryocytes available as well as the capacity to conttol the in vitro developmental environment, this technique should be a valuable tool for the study of human megakaryocytopoiesis and megakaryocyte cell biology.
MATERIALS AND METHODS

Human Subjects
Peripheral blood for megakaryocyte progenitor cell (CFU-Meg) cultures and normal AB plasma/serum were obtained by routine venipuncture from healthy adult donors, all of whom provided written informed consent.
Serum Meg-CSA
An established source of Meg-CSA was enriched from aplastic canine serum. The serum protein fraction containing Meg-CSA was prepared by ammonium sulfate salt precipitation at 60% saturation and desalting by gel chromatography as described."
Liquid Suspension Cultures of Human CFU-Meg
Normal human peripheral blood mononuclear cells were isolated by Ficoll 400-sodium diatrizoate (Pharmacia, Piscataway, NJ) density centrifugation. The mononuclear cell suspension was layered over an equal volume of fetal calf serum (FCS) and pelleted by slow centrifugation in order to remove platelets. Cells were resuspended in alpha medium containing 20% AB serum and plastic adherent cells were removed by an overnight incubation at 37OC in 100-mm polystyrene tissue culture dishes (Corning Glass Works, Corning, NY). For personal use only. on September 24, 2017. by guest www.bloodjournal.org From
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The adherent depleted mononuclear cell population was suspendd at 5 x 10' 10 l @ cells/mL in 10 10 30 mL voluma in tisuc culture flash (Corning Glass Works). No megakaryocres were identified by light microscopy in the initial cell hXuhm. The suspension medium consisted of 20% heparinized platelet poor human AB plasma in supplemented k a v e ' s modified D u~~s medium (lMDM; GIBC0* Grand Island* NY) with seNm Meg-CSA protein at I to 2 mg/mL af the growth stimulator. The Supplemented 1MDM was Prepad by adding each ofthe follming nutrients to 100 mL of IMDM: 1.0 mL each of l00x MEM nonessential amino acids, l00x L-glUlamine. and l 0 0 x minimal essential medium vitamins, 10% (wt/vol) deioniid bovine serum albumin, and IO ' mol/L alpha-thioglycerol ( 1 0 0~ supplements obtained from GIBCO). Suspension cultures were incubated for 12 to 13 days (unlcssothemise indicated) at 37-ina 100% humidified atmosphere of 5% CO? in air. For personal use only. on September 24, 2017. by guest www.bloodjournal.org From consisted of the noneluted cells and was collected by aspirating the contents of the Sanderson elutriation chamber. Megakaryocytes were retained in the chamber fraction although rare morphologically identifiable megakaryocytes ( t l % of total) eluted in the final two fractions (corresponding to flow rates of 42 and 44 mL/min). Cultured cells were washed once and resuspended in Mega-buffer with 0.1% sodium azide. Anti-platelet glycoprotein (GP) IIb/IIIa (AMAC, Westbrook, ME) was added at a 1:lOO dilution and incubated with frequent agitation at 4OC for 30 minutes. After washing the cells twice, spherical immunomagnetic beads (Dynabeads; Dynal, Great Neck, NY) were added at a bead to cell ratio of 1:lO. (This results in approximately 3 to IO beads per anticipated target megakaryocyte). The bead/cell mixture was incubated with frequent agitation at 4°C for 60 minutes. Cells bound to the immunomagnetic beads were collected by a magnetic particle concentrator (Advanced Magnetics, Cambridge, MA).6.'9
Enrichment o/Megukuryocyfes From Liquid
Megakaryocyte Analyses
For determinations of megakaryocyte frequency, stage and size, cells from the elutriation chamber fraction were mounted onto poly-L-lysine coated glass slides by cytocentrifugation (Shandon Cytospin 2, Sewickley, PA). Slides were Wright-Giemsa stained and megakaryocytes were identified by their characteristic light microscopic morphology. Megakaryocyte frequencies were determined by evaluating 363 to 3,945 (mean, 2,056) consecutive cells on the cytocentrifuge preparations. Diameters were calculated as the average of perpendicular measurements assessed using a calibrated eyepiece micrometer. Megakaryocytes were assigned to maturation stages I through IV using the criteria of Levine et a1.20.2'
For electron microscopy, elutriation enriched megakaryocytes were suspended in Karnovsky's fixative (5% glutaraldehyde and 4% paraformaldehyde in 0.1 mol/L cacodylate buffer, pH 7.2) for 30 minutes at 4OC, then pelleted by centrifugation and fixed overnight at 4OC. Fixed cells were washed in cacodylate buffer, post-fixed in osmium tetroxide, embedded in Epon, and stained with uranyl acetate and lead citrate at the Brown University core electron microscopy facility.
Immunomagnetic bead adherence.
Megakaryocyte surface membrane antigen expression and DNA content were evaluated using flow cytometry. Megakaryocytes were enriched by CCE and stained immunofluorescently in Mega-buffer containing 0.1% sodium azide at 4OC. Cells were double labeled with a primary murine monoclonal antibody and fluorescein tagged goat A positive green staining threshold was established using the megakaryocyte-free cultured lymphocytes which separated in the first elutriation fraction. Lymphocytes were stained identically to and concurrently with the megakaryocyte enriched fraction except that an irrelevant murine monoclonal antibody was substituted for the anti-platelet GP IIb/IIIa. The green gate was set such that the control lymphocyte population generated 0.6% to 0.7% positive events. This algorithm resulted in virtually 100% inclusion of all megakaryocytes A N .
RESULTS
Normal appearing megakaryocytes routinely developed in serum Meg-CSA stimulated liquid suspension cultures established with adherent depleted normal human peripheral blood mononuclear cells. After 12 to 13 days of incubation, the megakaryocytes in such cultures comprised an average of 3% of the total cell population (Tables 1 and 2) . In control day 12 cultures established without serum Meg-CSA, the megakaryocyte frequency was only 0.3 k 0.1% (+SD, n = 4). Culture derived megakaryocytes appeared morphologically normal on Wright-Giemsa stained cytocentrifuge preparations and exhibited varying size, stages of maturation, and extents of nuclear lobation (Fig 1) .
In order to facilitate most analyses, megakaryocytes were enriched from the liquid cultures using counterflow centrifugal elutriation. Enrichment averaged 36-fold resulting in final megakaryocyte frequencies of 36% to 73% and a mean viability of 67% ( Table 1) . Total cell recovery following CCE averaged 61 18% (*SD) while the mean megakaryocyte recovery was only 12.8 k 6.9% (2SD). Normalized by the volume of peripheral blood used for the culture inoculum, this algorithm resulted in the isolation of 2.9 x lo5 (k1.9 x lo5, [kSD]) megakaryocytes with an average purity of 58% from each normal blood donation of 100 mL.
In an attempt to improve on the low megakaryocyte recovery obtained using CCE, immunomagnetic bead adherence, an alternative separation algorithm, was applied to the liquid culture^.^.'^ This approach yielded highly variable results ( Table 2) . Megakaryocyte purities ranged from 13% to 67% and recoveries ranged from 20% to 2100%. Greater purities appeared to be obtained from those unseparated liquid cultures exhibiting the highest initial megakaryocyte frequencies. CCE resulted in a greater consistency in megakaryocyte purity and an easier subsequent analysis of cells by flow cytometry. Based on this experience, we chose CCE for routine megakaryocyte enrichment.
Size and maturation stage distributions were determined for CCE-enriched megakaryocytes on days 12 to 13 of culture ( Table 3 , Fig 2) . Among experiments, the overall pattern of distribution of megakaryocytes by maturation stage remained relatively constant. A majority of the megakaryocytes were distributed in stages I1 and 111: a mean of Table 3 ). The distribution histogram for cultured megakaryocyte diameter is presented in Fig 2. Modal megakaryocyte diameter was 30 pm and diameters ranged from 13.5 pm to 63 pm.
Megakaryocyte maturation stage distributions varied substantially with culture duration (Fig 3) . On day 9,54% of the cultured megakaryocytes were stage I1 and 24% were stage 111. By day 14 the inverse was observed; 63% of the cells were For personal use only. on September 24, 2017. by guest www.bloodjournal.org From stage 111 and 2 5 8 were stage II. Although partial synchrony in megakaryocyte maturation was present at culture intervals between 9 and 16 days, all maturation stages were detected at each culture interval (Fig 3) .
Ultrastructure of the culturederived megakaryocytes was well-preserved and similar to that of wild type, bone marrow derived megakaryocytes. Multi-lobulated nuclei (occasionally with nucleoli). large numbers of mitochondriae. Golgi apparatus. a-granules. and demarcation membrane formation were all identified (Fig 4) .
Surface membrane platelet glycoprotein expression and ploidy of the liquid culture derived megakaryocytes were evaluated using flow cytometry. Illustrated in Fig 5 is evident 4". 8N. I6N. and 32N peaks. The 2N control signal is derived from human peripheral blood lymphocytes that were stained and analyzed concurrently with the megakaryo- cytes. In a series of three separate liquid culture experiments. megakaryocyte ploidy distributions were very consistent (Table 4) . In all instances. modal megakaryocyte ploidy values were 16N and over 80% of the megakaryocytes exhibited ploidy values between 8% and 32N inclusive.
In selected experiments, megakaryocyte ploidy distributions were determined both before and after enrichment by CCE. For these analyses. megakaryocytes were identified by positive labeling for anti-platelet GP llb/llla. Figure 7 illustrates that CCE separation resulted in a disproportionate enrichment of high ploidy megakaryocytes. Modal ploidy shifted from 4N in the unseparatcd culture to 16% in the CCE-enriched preparation. These data are consistent with the known strong dependance of the CCE separation procedure on cell size. 16N with clearly defined 4N. EN, 16N. and 32N peeks. 
DISCUSSION
Heretofore. investigations of the regulatory control system governing megakaryocytopoiesis have proceeded almost independently of studies focusing on megakaryocyte biochcmistry and cell biology. The former has been greatly facilitated by the development of methods for in vitro culture of the megakaryocyte progenitor cell. functionally defined as the CFU-Meg." Studies of the latter type have depended on increasingly effective cell separation algorithms applied to intact bone marrow.'"." Only in the instance of mepakaryocyte ploidy have perturbations alTccting thrombopoictic regulation been linked to changes in cell biology.?" '' The recent identification and cloning of hematopoietic growth factors active in megakaryocytopoiesis39." and an increasing recognition of the influence of megakaryocyte development on platelet heterogeneity and function'' emphasize the importance of integrating these two areas of research.
In the current investigation, we present an approach that permits such an integration. Megakaryocytes that develop in liquid culture are likely to be derived entirely from progeni- Thus, the entire megakaryocytic developmental process including mitotic cell expansion, polyploidization, and cytoplasmic maturation occurs in an in vitro liquid environment that is growth factor driven and amenable to controlled manipulation. Enriched, culture-derived megakaryocytes should thus provide opportunities to study the effects of growth factor regulation on megakaryocyte cell biology. However, megakaryocytes developing in a liquid culture cannot be considered absolutely identical to those that are isolated from normal human bone marrow. The left-shifted ploidy distribution of the megakaryocytes in unenriched cultures is an example of such deviation from normal. These discrepancies may be due to intrinsic differences between peripheral blood and bone marrow megakaryocyte progenitors or more likely are due to the absence of required cytokine or stromal cell interactions in the liquid culture environment.
Both the apparent loss of low ploidy megakaryocytes and the relatively low megakaryocyte recovery following CCE enrichment also warrant comment. Small megakaryocytes are known to exhibit low ploidy and high density.32 Because cell sedimentation in the CCE chamber varies directly with both cell density and cell diameter squared, it is not surprising that small, relatively dense, low ploidy megakaryocytes are lost disproportionately. This loss probably accounts for the relatively large mean diameter of 22.2 bm we observed for enrich-, stage I megakaryocytes. Our megakaryocyte recovery following CCE (averaging only 13%), is significantly lower than that previously reported by others. Shoff and Levine' and Berkow et a19 have achieved megakaryocyte recoveries of 93% and 58%, respectively, using human bone marrow aspirates. We believe our relatively low recovery is inherent to the liquid culture system. It may result from the disproportionate percentage of small, low ploidy megakaryocytes in the unseparated cultures as well as from the excessive stickiness and fragility of liquid cultured cells. The variability in enrichment obtained using immunomagnetic adherence is also probably attributable to excessive cultured cell adhesiveness. Using immunomagnetic beads, nonspecific cell clumping appears to result in substantial "trapping" of non-megakaryocytes in the bead/megakaryocyte rosettes. Of note, however, is that the average 57% recovery we achieved with immunomagnetic adherence compares favorably with the 36% recovery reported by Tanaka et a1. 6 Unseparated megakaryocytes in liquid culture appear to be of lower ploidy and potentially are less mature. However, following CCE, the enriched megakaryocyte population exhibits stage and size distributions close to those previously reported for megakaryocytes isolated directly from normal bone m a r r~w .~' ,~~ Cultured megakaryocytes also express platelet GP Ib, GP IIb/IIIa, and CCE-enriched cells manifest DNA distributions that are similar to those exhibited by bone marrow megakaryocyte^.^^ Therefore, one may anticipate that the biology of CCE-enriched, culture-derived megakaryocytes will be comparable with that of their wild type, bone marrow counterparts.
The megakaryocyte purity and viability that are achiev- For personal use only. on September 24, 2017. by guest www.bloodjournal.org From able using cells grown in liquid culture are similar to those reported from intact human marrow cells ( Table 5) . Signifi- cantly, however, the megakaryocyte yields from liquid culture are achieved using a starting sample of only 100 mL of normal peripheral blood. Comparable megakaryocyte yields from normal human marrow require whole human ribs or large volume bone marrow aspirates as the starting materials (Table 5 ). In addition, the numbers of liquid cultured megakaryocytes may also be conveniently scaled up by using either larger peripheral blood donations or mononuclear cells harvested by leukopheresis for the culture inoculum.
This investigation establishes a new approach for obtaining relatively large populations of normal human megakaryocytes, megakaryocytes of moderately high purity generated in vitro under controlled conditions. This experimental algorithm should be a valuable tool with which to explore the effects of growth factor regulation on human megakaryocyte phenotype, biochemistry, and function. 
